SARAH ADKINS: Open Payments
NPI 1265039044 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 57 payments from 18 companies in 2025. Trend: 2023 $377 · 2024 $1,111 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $287 |
| Gilead Sciences, Inc. | 3 | $183 |
| Abbott Laboratories | 8 | $179 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Astellas Pharma US Inc | 3 | $63 |
| Lilly USA, LLC | 2 | $50 |
| ABBVIE INC. | 3 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $38 |
Products named: FREESTYLE LIBRE, Ozempic, AIRSUPRA, Yeztugo, LEQVIO, Veozah, JARDIANCE, GEMTESA.
Industry payments across TX — which companies pay providers there.
